全球股指期货表现 - 美股三大股指期货齐跌，道指期货跌0.63%至47,039.20，标普500指数期货跌0.99%至6,784.10，纳指期货跌1.28%至25,640.60 [1] - 欧洲主要股指普遍下跌，德国DAX指数跌1.25%，英国富时100指数跌0.59%，法国CAC40指数跌1.19%，欧洲斯托克50指数跌1.07% [2] 大宗商品市场动态 - 原油价格下跌，WTI原油跌1.46%至60.16美元/桶，布伦特原油跌1.26%至64.07美元/桶 [3] - 黄金期货自历史高点下跌近8%，但长期向好格局未变，回调被视为短暂休整 [6] - 铜价延续跌势，因美联储鹰派表态推升美元，美元指数过去一周涨超1%，报100.02 [6] 宏观经济与政策观点 - 华尔街资管机构CEO们预警股票市场估值过高，预计未来12-24个月内可能出现超过10%的健康回调 [4] - 美联储理事米兰主张进行超常规幅度降息，认为现行政策限制性过强，曾在9月和10月议息会议上主张降息50个基点 [5] - 美国财政部可能将国债发行进一步向短期期限倾斜，以控制长期收益率，本季度净借款额预估下调至5690亿美元 [7] 个股业绩与表现 - 特斯拉10月中国产汽车销量61,497辆，同比下降近10%，且大股东挪威主权财富基金公开反对马斯克的1万亿美元薪酬方案 [8] - Palantir第三季度营收同比增长63%至11.8亿美元，净利润同比激增逾两倍至4.756亿美元，但盘前股价跌超7% [9] - 辉瑞第三季度营收166.5亿美元超预期，调整后每股收益0.87美元，并上调全年盈利指引 [10] - 飞利浦第三季度可比销售额增长3%，北美地区增长5%，经调整EBITA为5.31亿欧元超预期，盘前股价涨超3% [11] - 英国石油第三季度基础重置成本利润22.1亿美元超预期，炼油利润率走强抵消油价疲软，维持季度股票回购规模7.5亿美元 [12] - 百胜中国第三季度经营利润同比增长8%，同店交易量连续第11个季度增长，净新增门店536家，盘前股价涨超2% [13] 即将发布业绩的公司 - 周三早间发布业绩的公司包括AMD、Arista Networks、Tempus AI等 [14] - 周三盘前发布业绩的公司包括丰田、诺和诺德、麦当劳、Cameco等 [14]

Pfizer reported lower third-quarter profit as demand for its Covid-19 vaccine and antiviral drug continue to decline. ...

格隆汇11月4日｜辉瑞(PFE.US)盘前涨超2%。消息面上，辉瑞第三季度营收166.5亿美元，预估165.9亿 美元；调整后每股收益0.87美元。辉瑞仍然预测全年营收610亿美元至640亿美元。预计全年调整后每股 收益3-3.15美元，此前预计2.9-3.1美元。 ...

Exhibit 99 Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance NEW YORK, Tuesday, November 4, 2025 — Pfizer Inc. (NYSE: PFE) reported financial results for the third quarter of 2025 and reaffirmed its 2025 Revenue guidance while raising and narrowing guidance for Adjusted diluted EPS. (1) (2) EXECUTIVE COMMENTARY Dr. Albert Bourla, Chairman and CEO of Pfizer: "I am proud of Pfizer's leadership as the first in our industry to reach an agreement with the U.S. Government, whic ...

Pfizer on Thursday reported third-quarter earnings and revenue that topped estimates and hiked its full-year profit guidance, as cost cuts helped to outweigh declining sales for the period fell.Here's what the company reported for the third quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG:Earnings per share: 87 cents adjusted vs. 63 cents expectedRevenue: $16.65 billion vs. $16.58 billion expectedThe results come weeks after Pfizer became the first drugmaker to str ...

市场有风险，投资需谨慎。本文不构成个人投资建议，也未考虑到个别用户特殊的投资目标、财务状况或需要。用户应考虑本文中的任何 意见、观点或结论是否符合其特定状况。据此投资，责任自负。 辉瑞第三季度调整后每股收益0.87美元。 辉瑞仍然预测全年营收610亿美元至640亿美元。 辉瑞预计全 年调整后每股收益3-3.15美元，此前预计2.9-3.1美元。 辉瑞美股盘前涨逾2%。 风险提示及免责条款 ...

Pfizer lifted its full-year profit forecast for the second time in a row on Tuesday, buoyed by strong demand for its blockbuster heart treatment and blood thinner. ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Nov 4, 2025 6:45 AM Eastern Standard Time Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance Share NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) reported financial results for the third quarter of 2025 and reaffirmed its 2025 Revenue guidance while raising and narrowing guidance for Adjusted diluted EPS. EXECUTIVE COMMENTARY Dr. Albert Bourla, Chairman and CEO of Pfizer: "I am proud of Pfizer's leadership as the first in our industry to reach an agreement with the U.S ...

市场表现 - 美国股票期货市场表现疲软 呈下跌态势 [1] 即将发布财报的公司 - 超微公司即将公布业绩 [1] - 优步公司即将公布业绩 [1] - 辉瑞公司即将公布业绩 [1] - 汤森路透公司即将公布业绩 [1]